Gene · 27242
Papers1,638
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,638
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of WNT10A in papillary thyroid carcinoma and its effect on cell proliferation, invasion, and metastasis. | Zhong Nan Da Xue Xue Bao Yi Xue Ban | 2025 | 40628509 | PubTator, text mining | PubMed |
| The role of fibroblast-neutrophil crosstalk in the pathogenesis of inflammatory diseases: a multi-tissue perspective. | Front Immunol | 2025 | 40486514 | PubTator, text mining | PubMed |
| A diet-driven metabolic dysfunction-associated steatohepatitis (MASH) mouse model resembles the corresponding human disease. | J Mol Histol | 2025 | 40392411 | PubTator, text mining | PubMed |
| Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients. | Front Immunol | 2025 | 40370459 | PubTator, text mining | PubMed |
| Integrating Machine Learning and Bulk and Single-Cell RNA Sequencing to Decipher Diverse Cell Death Patterns for Predicting the Prognosis of Neoadjuvant Chemotherapy in Breast Cancer. | Int J Mol Sci | 2025 | 40332226 | PubTator, text mining | PubMed |
| Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy. | BMC Cancer | 2025 | 40221689 | PubTator, text mining | PubMed |
| A Novel Systemic siDR6 Delivery System Based on DP7-C for the Treatment of Metastatic Lung Cancer. | Int J Nanomedicine | 2025 | 40125426 | PubTator, text mining | PubMed |
| Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinoma. | Oncol Res | 2025 | 40109864 | PubTator, text mining | PubMed |
| Identifying Lipid Metabolism-Related Therapeutic Targets and Diagnostic Markers for Lung Adenocarcinoma by Mendelian Randomization and Machine Learning Analysis. | Thorac Cancer | 2025 | 40107973 | PubTator, text mining | PubMed |
| [Rhupus syndrome: Description of 9 cases with special attention to the HLA-DR genotype]. | Med Clin (Barc) | 2025 | 39516107 | PubTator, text mining | PubMed |
| LPA suppresses HLA-DR expression in human melanoma cells: a potential immune escape mechanism involving LPAR1 and DR6-mediated release of IL-10. | Acta Pharmacol Sin | 2025 | 39187677 | PubTator, text mining | PubMed |
| DR6 Augments Colorectal Cancer Cell Growth, Invasion, and Stemness by Activating AKT/NF-κB Pathway. | Biochem Genet | 2025 | 38478147 | PubTator, text mining | PubMed |
| Protein phase change batteries drive innate immune signaling and cell fate. | bioRxiv | 2025 | 36993308 | PubTator, text mining | PubMed |
| FOLR2+ macrophage depletion from intestinal metaplasia to early gastric cancer: single-cell sequencing insight into gastric cancer progression. | J Exp Clin Cancer Res | 2024 | 39702278 | PubTator, text mining | PubMed |
| Cytokine profiling reveals HLA-linked Th2 and Th17 driven immune activation in pemphigus vulgaris patients and genetically susceptible healthy controls. | Front Immunol | 2024 | 39697331 | PubTator, text mining | PubMed |
| Development and experimental verification of novel angiogenesis related prognostic model and immune infiltration characterization in osteosarcoma. | Discov Oncol | 2024 | 39237807 | PubTator, text mining | PubMed |
| Exploration of ferroptosis and necroptosis-related genes and potential molecular mechanisms in psoriasis and atherosclerosis. | Front Immunol | 2024 | 39072329 | PubTator, text mining | PubMed |
| eEF1A1 regulates the expression and alternative splicing of genes associated with Parkinson's disease in U251 cells. | Genes Genomics | 2024 | 38776049 | PubTator, text mining | PubMed |
| RNA velocity prediction via neural ordinary differential equation. | iScience | 2024 | 38623336 | PubTator, text mining | PubMed |
| The prognostic value of MEK pathway-associated estrogen receptor signaling activity for female cancers. | Br J Cancer | 2024 | 38582811 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/27242/papers?page=3